glp-1 drugs and fatty liver Multiple target tissue effects of analogues on non-alcoholic disease (NAFLD) non-alcoholic steatohepatitis (NASH) glp-1 drugs and fatty liver

Suppression of basal autophagy in neural cells causes neurodegenerative Disease in mice

Protocol approach: post-surgical shoulder recovery Goal: Accelerate healing, reduce retear risk, optimize tissue quality Peptide approach: BPC-157: 300 to 500 mcg daily, starting as soon as cleared by surgeon (typically one to two weeks post-op) TB-500: 750 to 1000 mcg twice weekly GHK-Cu: 200 to 400 mcg daily from week three to four post-op Duration: Eight to sixteen weeks, aligned with surgical recovery timeline Critical notes: Any peptide use after surgery should be discussed with and approved by the operating surgeon

Here is the problem most people do not think about

Three-dimensional reconstruction of parenchymal units in the liver of the rat

Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L, Levin MG, Thacker S, Sethupathy P, Barter PJ, Remaley AT, Rye KA